Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
A.BazylianskaV.RecanatiM
Chemical Properties of Cagrilintide Research Applications Receptor Binding Studies Cagrilintide is utilized in experimental systems to examine ligand interaction with amylin receptor complexes
This product is strictly for research use only
Synergistic Healing Effects BPC-157 (Body Protective Compound) is known for accelerating gut healing, tendon repair, and soft tissue regeneration
And in animal models, glucagon activates brown fat thermogenesis, essentially turning up the body metabolic furnace to burn more calories as heat
Side-by-Side Comparison Parameter Receptors Cagrilintide AMY1R/2R/3R + CTR Semaglutide GLP-1R Tirzepatide GLP-1R + GIPR Retatrutide GLP-1R + GIPR + Glucagon-R Parameter Half-life Cagrilintide ~7-8 days Semaglutide ~7 days Tirzepatide ~5 days Retatrutide ~6 days Parameter Dosing frequency Cagrilintide Once weekly Semaglutide Once weekly Tirzepatide Once weekly Retatrutide Once weekly Parameter Max studied dose Cagrilintide 4.5 mg/week (mono) Semaglutide 2.4 mg/week Tirzepatide 15 mg/week Retatrutide 12 mg/week Parameter Peak monotherapy weight loss Cagrilintide 11.8% at 68 wk Semaglutide 14.9-17% at 68 wk Tirzepatide 22.5% at 72 wk Retatrutide ~24% at 48 wk Parameter FDA status (June 2026) Cagrilintide Investigational Semaglutide Approved (2021) Tirzepatide Approved (2023) Retatrutide Investigational Parameter HbA1c reduction (T2D) Cagrilintide ~0.9 pp mono
US$ 21.64
US$ 22.62
US$ 28.81
![VitaHealth L-Glutathione Plus [Exp 8/2028]](https://down-my.img.susercontent.com/file/my-11134207-7qul4-lir57h2q4ztvd9)
US$ 20.06
US$ 20.70
US$ 21.86
